메뉴 건너뛰기




Volumn 14, Issue 4, 2010, Pages 1015-1020

Prediction of drug degradation pathways leading to structural alerts for potential genotoxic impurities

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC AMINES; CAMBRIDGESOFT; DEGRADATION PATHWAYS; GENOTOXIC IMPURITIES; GENOTOXICITIES; IN-DEPTH ANALYSIS; PARENT MOLECULES; PHARMACEUTICAL DRUGS; POLYAROMATIC HYDROCARBONS; SECOND PHASE; TWO-STEP APPROACH;

EID: 77955357282     PISSN: 10836160     EISSN: 1520586X     Source Type: Journal    
DOI: 10.1021/op100007q     Document Type: Article
Times cited : (31)

References (21)
  • 1
    • 55849151593 scopus 로고    scopus 로고
    • CPMP/SWP/5199/02, EMEA/CHMP/QWP/251344/2006; Committee for Medicinal Products for Human Use (CHMP), European Medicines Agency (EMEA): London, 28 June
    • Guideline on the Limits of Genotoxic Impurities, CPMP/SWP/5199/02, EMEA/CHMP/QWP/251344/2006; Committee for Medicinal Products for Human Use (CHMP), European Medicines Agency (EMEA): London, 28 June 2006
    • (2006) Guideline on the Limits of Genotoxic Impurities
  • 2
    • 77955404336 scopus 로고    scopus 로고
    • Committee for Medicinal Products for Human Use Safety Working Party(CHMP), European Medicines Agency (EMEA): London
    • Questions and answers on the CHMP guideline on the limits of genotoxic impurities,; Committee for Medicinal Products for Human Use Safety Working Party(CHMP), European Medicines Agency (EMEA): London 2008
    • (2008) Questions and Answers on the CHMP Guideline on the Limits of Genotoxic Impurities
  • 3
    • 76749103090 scopus 로고    scopus 로고
    • Guidance for Industry (draft); U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER): Rockville, MD.
    • Genotoxic and carcinogenic impurities in drug substances and drug products: Recommended approaches, Guidance for Industry (draft); U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER): Rockville, MD, 2008; http://www.fda.gov/ downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm079235.pdf.
    • (2008) Genotoxic and Carcinogenic Impurities in Drug Substances and Drug Products: Recommended Approaches
  • 5
    • 65949108606 scopus 로고    scopus 로고
    • Approaches to assessment testing decisions and analytical determination of genotoxic impurities in drug substances
    • Pierson, D. Approaches to assessment testing decisions and analytical determination of genotoxic impurities in drug substances Org. Process Res. Dev. 2009, 13 (2) 285-291
    • (2009) Org. Process Res. Dev. , vol.13 , Issue.2 , pp. 285-291
    • Pierson, D.1
  • 6
    • 77955363626 scopus 로고    scopus 로고
    • Genotoxic impurities: A case for regulatory rethink
    • FEB
    • Snodin, D.; Vudathala, G. K. Genotoxic impurities: A case for regulatory rethink AAPS Mag. 2009, Feb) 20-26
    • (2009) AAPS Mag. , pp. 20-26
    • Snodin, D.1    Vudathala, G.K.2
  • 7
    • 0033968631 scopus 로고    scopus 로고
    • First derivative spectroscopy and LC determination of benoxinate hydrochloride and its degradation Products
    • El-Grindy, A. First derivative spectroscopy and LC determination of benoxinate hydrochloride and its degradation Products J. Pharm. Biomed. Anal. 2000, 22, 215-234
    • (2000) J. Pharm. Biomed. Anal. , vol.22 , pp. 215-234
    • El-Grindy, A.1
  • 8
    • 33645866459 scopus 로고    scopus 로고
    • The application of structure-based assessment to support safety and chemistry diligence to manage genotoxic impurities in active pharmaceutical ingredients during drug development
    • 3, APRIL
    • Dobo, K. L.; Greene, N; Cyr, M. O.; Caron, S; Ku, W. W. The application of structure-based assessment to support safety and chemistry diligence to manage genotoxic impurities in active pharmaceutical ingredients during drug development Regul. Toxicol. Pharmacol. 2006, 44 (3, April) 282-293
    • (2006) Regul. Toxicol. Pharmacol. , vol.44 , pp. 282-293
    • Dobo, K.L.1    Greene, N.2    Cyr, M.O.3    Caron, S.4    Ku, W.W.5
  • 11
    • 49849084348 scopus 로고    scopus 로고
    • Structure alerts for carcinogenicity, and the Salmonella assay system: A novel insight through the chemical relational databases technology
    • 3, SEP-OCT
    • Benigni, R.; Bossa, C. Structure alerts for carcinogenicity, and the Salmonella assay system: A novel insight through the chemical relational databases technology Mutat. Res. 2008, 659 (3, Sep-Oct) 248-261
    • (2008) Mutat. Res. , vol.659 , pp. 248-261
    • Benigni, R.1    Bossa, C.2
  • 12
    • 77955404263 scopus 로고    scopus 로고
    • http://www.inchem.org/documents/jecfa/jecmono/v52je14.htm.
  • 14
    • 77955355652 scopus 로고    scopus 로고
    • http://www.inchem.org/documents/jecfa/jecmono/v040je10.htm.
  • 15
    • 77955351849 scopus 로고    scopus 로고
    • http://www.inchem.org/documents/jecfa/jecmono/v040je11.htm.
  • 16
    • 77955366209 scopus 로고    scopus 로고
    • http://www.inchem.org/documents/jecfa/jecmono/v52je15.htm.
  • 17
    • 37349002009 scopus 로고    scopus 로고
    • Mechanistic QSAR of aromatic amines: New models for discriminating between homocyclic mutagens and nonmutagens, and validation of models for carcinogens
    • 9, DEC
    • Benigni, R.; Bossa, C.; Netzeva, T.; Rodomonte, A.; Tsakovska, I. Mechanistic QSAR of aromatic amines: New models for discriminating between homocyclic mutagens and nonmutagens, and validation of models for carcinogens Environ. Mol. Mutagen. 2007, 48 (9, Dec) 754-771
    • (2007) Environ. Mol. Mutagen. , vol.48 , pp. 754-771
    • Benigni, R.1    Bossa, C.2    Netzeva, T.3    Rodomonte, A.4    Tsakovska, I.5
  • 18
    • 0035889635 scopus 로고    scopus 로고
    • Transformation of mutagenic aromatic amines into non-mutagenic species by alkyl substituents. Part I. Alkylation ortho to the amino function
    • 1-2, NOV 15
    • Glende, C.; Schmitt, H.; Erdinger, L.; Engelhardt, G.; Boche, G. Transformation of mutagenic aromatic amines into non-mutagenic species by alkyl substituents. Part I. Alkylation ortho to the amino function Mutat. Res. 2001, 498 (1-2, Nov 15) 19-37
    • (2001) Mutat. Res. , vol.498 , pp. 19-37
    • Glende, C.1    Schmitt, H.2    Erdinger, L.3    Engelhardt, G.4    Boche, G.5
  • 19
    • 0037170698 scopus 로고    scopus 로고
    • Transformation of mutagenic aromatic amines into non-mutagenic species by alkyl substituents. Part II: Alkylation far away from the amino function
    • 1-2, MAR 25
    • Glende, C.; Klein, M.; Schmitt, H.; Erdinger, L.; Boche, G. Transformation of mutagenic aromatic amines into non-mutagenic species by alkyl substituents. Part II: Alkylation far away from the amino function Mutat. Res. 2002, 515 (1-2, Mar 25) 15-38
    • (2002) Mutat. Res. , vol.515 , pp. 15-38
    • Glende, C.1    Klein, M.2    Schmitt, H.3    Erdinger, L.4    Boche, G.5
  • 20
    • 77955356382 scopus 로고    scopus 로고
    • http://dra4.nihs.go.jp/mhlw-data/home/file/file123-30-8.html.
  • 21
    • 77955390462 scopus 로고    scopus 로고
    • http://ntp.niehs.nih.gov/index.cfm?objectid=BD08DB0A-123F-7908- 7B82B481A44725F0.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.